These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
369 related items for PubMed ID: 22040641
1. [Short-tau inversion-recovery (STIR) sequence magnetic resonance imaging evaluation of orbital structures in Graves' orbitopathy]. Rodríguez-González N, Pérez-Rico C, López-Para Giménez R, Arévalo-Serrano J, Del Amo García B, Calzada Domingo L, Flores Ruiz L, Blanco R. Arch Soc Esp Oftalmol; 2011 Nov; 86(11):351-7. PubMed ID: 22040641 [Abstract] [Full Text] [Related]
2. Evaluation of rectus extraocular muscles using dynamic contrast-enhanced MR imaging in patients with Graves' ophthalmopathy for assessment of disease activity. Jiang H, Wang Z, Xian J, Li J, Chen Q, Ai L. Acta Radiol; 2012 Feb 01; 53(1):87-94. PubMed ID: 22184678 [Abstract] [Full Text] [Related]
3. [Management of Graves' ophthalmopathy by using orbital magnetic resonance imaging]. Hiromatsu Y, Eguchi H, Tani J. Nihon Rinsho; 2012 Nov 01; 70(11):1932-7. PubMed ID: 23214064 [Abstract] [Full Text] [Related]
4. Signal intensity, clinical activity and cross-sectional areas on MRI scans in thyroid eye disease. Mayer EJ, Fox DL, Herdman G, Hsuan J, Kabala J, Goddard P, Potts MJ, Lee RW. Eur J Radiol; 2005 Oct 01; 56(1):20-4. PubMed ID: 15896938 [Abstract] [Full Text] [Related]
12. Novel use of non-echo-planar diffusion weighted MRI in monitoring disease activity and treatment response in active Grave's orbitopathy: An initial observational cohort study. Lingam RK, Mundada P, Lee V. Orbit; 2018 Oct 01; 37(5):325-330. PubMed ID: 29319381 [Abstract] [Full Text] [Related]
14. [The course of the disease in endocrine orbitopathy. Magnetic resonance tomographic documentation]. Hosten N, Schörner W, Lietz A, Wenzel KW. Rofo; 1992 Sep 01; 157(3):210-4. PubMed ID: 1391813 [Abstract] [Full Text] [Related]
15. Sustained control of Graves' hyperthyroidism during long-term low-dose antithyroid drug therapy of patients with severe Graves' orbitopathy. Laurberg P, Berman DC, Andersen S, Bülow Pedersen I. Thyroid; 2011 Sep 01; 21(9):951-6. PubMed ID: 21834677 [Abstract] [Full Text] [Related]
16. Using morphologic parameters of extraocular muscles for diagnosis and follow-up of Graves' ophthalmopathy: diameters, areas, or volumes? Szucs-Farkas Z, Toth J, Balazs E, Galuska L, Burman KD, Karanyi Z, Leovey A, Nagy EV. AJR Am J Roentgenol; 2002 Oct 01; 179(4):1005-10. PubMed ID: 12239055 [Abstract] [Full Text] [Related]
17. Application of Multiparameter Quantitative Magnetic Resonance Imaging in the Evaluation of Graves' Ophthalmopathy. Li Z, Luo Y, Feng X, Zhang Q, Zhong Q, Weng C, Chen Z, Shen J. J Magn Reson Imaging; 2023 Oct 01; 58(4):1279-1289. PubMed ID: 36780178 [Abstract] [Full Text] [Related]
20. Quantitative assessment of extraocular muscles in Graves' ophthalmopathy using T1 mapping. Zhu H, Zou M, Wu D, Li B, Su Y, Li Y, Hong S, Yang Z. Eur Radiol; 2023 Dec 01; 33(12):9074-9083. PubMed ID: 37466707 [Abstract] [Full Text] [Related] Page: [Next] [New Search]